Выпуск
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
Pharmaceutical Executive · 22 октября 2026 г. · 2 мин
FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI Proteins’ collaboration with Astellas, and Incubate’s John Stanford on which therapeutic areas MFN deals might hit hardest.